News Alzheimer's drug Leqembi launched in first EU markets Germany and Austria are the first countries in the EU to see the launch of Leqembi, Eisai and Biogen's much-delayed treatment for Alzheimer's.
News Healthcare bills to pay? Let hi.health pick up the tab Just over a year ago, hi.health launched an app that takes the legwork out of submitting reimbursement claims to private health insurers.
Partner Content Partner Content Anthill extends its presence in DACH region Anthill, a digital communications agency focused on the life science industry, is expanding its services for local clients based in Germany, Austria and Switzerland.
News EMA advisors say CSL's Tavneos should be pulled from sale Pressure is building on Amgen to withdraw rare disease therapy Tavneos, after the CHMP recommended its marketing authorisation by revoked in the EU.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.